Filter
5035
Text search:
Drug
research
Featured
Recommendations
425
New Publications
1261
Language
Document type
No document type
2971
Studies & Reports
885
Guidelines
619
Manuals
206
Strategic & Response Plan
162
Fact sheets
74
Training Material
60
Situation Updates
17
Infographics
12
Brochures
11
Resource Platforms
11
Online Courses
3
App
2
Videos
2
Countries / Regions
India
273
Global
183
Kenya
157
South Africa
112
Western and Central Europe
110
Uganda
109
Ethiopia
108
Nigeria
105
Nepal
89
Tanzania
84
Africa
84
Zambia
79
Malawi
78
Liberia
77
Sierra Leone
73
Latin America and the Carribbean
69
Ghana
67
Myanmar / Burma
67
Bangladesh
63
Ukraine
56
Eastern Europe
56
Rwanda
53
Namibia
44
Asia
44
Philippines
43
Russia
42
Zimbabwe
39
Cambodia
36
Lesotho
32
South–East Asia Region
32
Indonesia
30
Mozambique
25
Congo, Democratic Republic of
23
Brazil
22
Botswana
22
Senegal
20
Syria
20
Germany
18
Burkina Faso
17
Eswatini/ Swaziland
17
East and Southern Africa
17
South Sudan
16
Colombia
16
Cameroon
14
West and Central Africa
14
Tajikistan
14
USA
13
Haiti
13
Thailand
13
Middle East and North Africa
13
Pakistan
11
China
11
Eastern Europe and Central Asia
11
Vietnam
11
Sudan
10
Argentina
10
Albania
10
Georgia
10
Guinea
9
Afghanistan
8
Venezuela
8
Laos
8
North Macedonia
7
Benin
6
Sri Lanka
6
Armenia
6
Moldova
6
Iraq
5
Mexico
5
Yemen
5
Western Pacific Region
5
Jordan
4
Lebanon
4
Central African Republic
4
Peru
4
Angola
4
Timor Leste/ East Timor
4
Iran
4
United Kingdom
4
Guinea-Bissau
3
Somalia
3
Turkey
3
Papua New Guinea
3
Serbia
3
El Salvador
3
Libya
3
Chile
3
Paraguay
3
Bhutan
3
Kyrgyzstan
3
North America
3
Jamaica
3
Belarus
3
Mali
2
Morocco
2
Saudi Arabia
2
Hungary
2
Honduras
2
Ecuador
2
Poland
2
Palestine
2
Southern Africa
2
Canada
2
Estonia
2
Kazakhstan
2
Belgium
2
Portugal
2
Côte d’Ivoire / Ivory Coast
1
Egypt
1
Chad
1
Gambia
1
Ireland
1
Singapore
1
Dominican Republic
1
Bolivia
1
Greece
1
Guatemala
1
Nicaragua
1
Fiji
1
North Korea
1
Italy
1
Mongolia
1
Qatar
1
Romania
1
Uzbekistan
1
Australia
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
1849
Clinical Guidelines
427
Public Health
240
Women & Child Health
179
Key Resources
124
Pharmacy & Technologies
66
Capacity Building
64
Annual Report MEDBOX
1
Toolboxes
HIV
603
Mental Health
569
TB
505
AMR
267
NTDs
236
COVID-19
210
Pharmacy
125
NCDs
106
Malaria
99
Caregiver
86
Ebola & Marburg
80
Planetary Health
74
Rapid Response
56
Disability
55
Refugee
54
Global Health Education
53
Conflict
44
Health Financing Toolbox
43
2.0 Rapid Response
23
Polio
20
Natural Hazards
16
Zika
16
Specific Hazards
15
Social Ethics
13
Cholera
11
Accessed online January 2019, publication date unknown.
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide. World Health Organization.
The ACT Consortium was an international research collaboration dedicated to evaluating the effectiveness, safety and implementation of artemisinin-based combination therapies (ACTs) for treating malaria. Operating across multiple countries in Africa
...
Chagas disease is a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi. It is a significant public health problem, affecting millions of people worldwide. And although it was described 110 years ago, only two old nitroheterocyclic drugs, benznidazole and nifurtimox, are cu
...
Developed through broad and inclusive consultation, and aligned with the WHO Global Health Sector Strategies and the Sustainable Development Goals, the framework promotes a people-centred approach and antimicrobial stewardship across 5 key domains: prevention and response, surveillance,
...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Cha
...
The protozoan parasite Trypanosoma cruzi causes Chagas disease, an important public health problem throughout Latin America. Current therapeutic options are characterised by limited efficacy, long treatment regimens and frequent toxic side-effects. Advances in this area have been compromised by gaps
...
Background: Despite several cycles of Mass Drug Administration (MDA), however, the prevalence of Soil-transmitted helminthiasis (STH) remains high in Bangladesh. A clear understanding of local knowledge, attitudes, and practices (KAP) related to the
...
EClinicalMedicine 1 (2018) 21–27
https://doi.org/10.1016/j.eclinm.2018.06.005
2589-5370/© 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
EClinicalMedicine: journal homepage: https://www.jo
...
The pamphlet "Oxycodone" provides an overview of the opioid drug class, explaining its uses, effects, and risks. It describes positive effects like euphoria and pain relief, alongside negative effects such as respiratory depression, confusion, and c
...
The pamphlet "What is Addiction" explains addiction as a chronic, relapsing brain disease characterized by compulsive drug seeking and use, despite harmful consequences. It highlights the dangers of different
...
Antimicrobial Resistance Surveillance and Research Network | This manual describes well accepted methods to carry out drug susceptibility testing on important gram positive and gram negative clinica
...
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i
...
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to pa
...
Chagas disease affects approximately 6 million people, mainly in Latin America. Less than 1% of affected individuals receive proper antiparasitic treatment, and current drugs are inadequate to fight the entire spectrum of the disease. Against this background, Novartis is pursuing an end-to-end appro
...